title: Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia.
authors.affiliation: Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan. r-koba@jacls.jp
authors.forename: Ryoji
authors.initials: R
authors.lastname: Kobayashi
authors.forename: Kuniko
authors.initials: K
authors.lastname: Takanashi
authors.forename: Daisuke
authors.initials: D
authors.lastname: Suzuki
authors.forename: Takashi
authors.initials: T
authors.lastname: Nasu
authors.forename: Kimiaki
authors.initials: K
authors.lastname: Uetake
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Matsumoto
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D017726:Cytomegalovirus Retinitis / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D017245:Foscarnet / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D051359:Lymphohistiocytosis, Hemophagocytic; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000097:blood; D008775:Methylprednisolone / Q000008:administration & dosage; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011239:Prednisolone / Q000097:blood; D012008:Recurrence; D012163:Retinal Detachment / Q000150:complications; D014750:Vincristine / Q000097:blood
chemical_list: D000964:Antimetabolites, Antineoplastic; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D017245:Foscarnet; D014750:Vincristine; D011239:Prednisolone; D007770:L-Lactate Dehydrogenase; D008775:Methylprednisolone; D008727:Methotrexate